Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
74,670,636
-
Shares change
-
+6,684,756
-
Total reported value, excl. options
-
$1,243,600,896
-
Value change
-
+$90,934,572
-
Put/Call ratio
-
19.6%
-
Number of buys
-
103
-
Number of sells
-
-85
-
Price
-
$16.65
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q4 2017
229 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q4 2017.
IMPAX LABORATORIES INC - COM (IPXL) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74,670,636 shares
.
Largest 10 shareholders include BlackRock Inc. (9,837,282 shares), MAVERICK CAPITAL LTD (7,327,798 shares), Vanguard Group Inc (7,036,174 shares), WELLINGTON MANAGEMENT GROUP LLP (4,136,625 shares), Fosun International Ltd (3,854,995 shares), AMERIPRISE FINANCIAL INC (3,245,821 shares), DIMENSIONAL FUND ADVISORS LP (2,979,998 shares), STATE STREET CORP (2,510,662 shares), TCW GROUP INC (1,987,950 shares), and Invesco Ltd. (1,891,554 shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.